 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Theralink Technologies, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. The firm with its proprietary vaccine technology operates through the following segments: Research Use Only, CAP/CLIA Certified Laboratory, and CLIA Approved Laboratory. The company was founded on March 18, 2005 and is headquartered in Golden, CO.

Watchers	199
52-Wk Low	$0.0007
52-Wk High	$0.015

Market Cap	$9.84M
Volume (M)	58,992.00
52-Wk High	$0.015
52-Wk Low	$0.0007

Current Price	$1.56
Prev Close	$2.48
Open	$2.60
Dividend Yield	0.00%
50-Day Moving Average	$0.0011
Beta	0.69
Avg. Volume	3.54M
PE Ratio	-0.18

52-Week High	$0.015
52-Week Low	$0.0007
Market Capitalization	$9.84M
EPS	-$0.0087
Price to Book	-0.21
Revenue Per Employee	$38,565.58
Enterprise Value/EBITDA	-4.84

OBMP OncBioMune Pharmaceuticals Inc

About

Feed

News

Fundamentals